Kanabo Group (LON:KNB) Shares Down 8% – What’s Next?

Shares of Kanabo Group Plc (LON:KNBGet Free Report) were down 8% on Wednesday . The stock traded as low as GBX 0.83 ($0.01) and last traded at GBX 0.83 ($0.01). Approximately 119,731 shares traded hands during trading, a decline of 51% from the average daily volume of 245,581 shares. The stock had previously closed at GBX 0.90 ($0.01).

Kanabo Group Stock Performance

The stock has a market cap of £5.57 million, a price-to-earnings ratio of -88.00 and a beta of 3.04. The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.49. The company has a 50 day simple moving average of GBX 0.93 and a 200 day simple moving average of GBX 1.13.

Kanabo Group Company Profile

(Get Free Report)

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers.

Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment.

See Also

Receive News & Ratings for Kanabo Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kanabo Group and related companies with MarketBeat.com's FREE daily email newsletter.